Fri, November 11, 2022
Thu, November 10, 2022
Wed, November 9, 2022

Ed Arce Maintained (ABUS) at Strong Buy with Decreased Target to $6 on, Nov 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-6-on-nov-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Maintained "Arbutus Biopharma Corporation" (ABUS) at Strong Buy with Decreased Target from $7.5 to $6 on, Nov 10th, 2022.

Ed, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources